Offstream
news

---

Changes

1. Moderna will build a vaccine manufacturing facility in Kenya to produce mRNA vaccines, including its COVID-19 vaccine.
   2022-03-07 21:10:30 (First version)
2. It is announced that Moderna will build a vaccine manufacturing facility in Kenya to produce mRNA vaccines, including its COVID-19 vaccine.
   (Current version)

---

Related

Moderna begins a study and a phase 2 trial of a hybrid vaccine aimed at combating the Omicron variant with their current COVID-19 vaccine.
2022-03-10

The European Medicines Agency approves the usage of the Moderna COVID-19 vaccine for children between the ages of 12 and 17, becoming the first time the vaccine has been authorised for people under the age of 18.
2021-07-23

Saudi Arabia approves the COVID-19 vaccine developed by Moderna.
2021-07-9

A study shows that the vaccine developed by Moderna is effective against SARS-CoV-2 variants including the Lineage B.1.617 Delta variant.
2021-06-29

The United States sends 2.5 million doses of Moderna’s vaccine to Taiwan.
2021-06-20

The United States government purchases 200 million doses of the vaccine produced by Moderna.
2021-06-16

Moderna says that their vaccine is 100% effective in teenagers between the ages of 12 and 17. They say that they will seek approval from the U.S. Food and Drug Administration in early June.
2021-05-25

The European Commission signs a deal with Moderna to secure additional 300 million doses of the vaccine in the European Union.
2021-02-17

Palau receives 2,800 doses of the Moderna vaccine in a special contribution from the United States. The government announced that it will vaccinate healthcare workers first and then vaccinate seniors and people with medical conditions.
2021-01-2

Health Canada approves the Moderna vaccine and expects that up to 168,000 doses will arrive in Canada by the end of the year.
2020-12-23